Searchable abstracts of presentations at key conferences in endocrinology

ea0077p156 | Bone and Calcium | SFEBES2021

Primary Cinacalcet therapy is safe and effective as alternative or bridging modality in Primary Hyperparathyroidism

Nge Nge Nyein , Malik Mohamed

Purpose: To evaluate long-term safety and efficacy of cinacalcet in management of primary hyperparathyroidism (PHPT).Material/Methods: We retrospectively studied all patients on cinacalcet for primary hyperparathyroidism over 3 yearÂ’s period. Data was collected and analyzed for indication, daily maintenance dose, tolerability, biochemical effect at 3, 6 and 12 months, effect on bone mineral density and renal stone disease. This study excluded those ...

ea0081p41 | Calcium and Bone | ECE2022

Lower than recommended doses of cinacalcet are effective and well tolerated in the control of hypercalcaemia of primary hyperparathyroidism

Nge Nge Nyein , Malik Mohamed

Background: The treatment goal in primary hyperparathyroidism (PHPT) is the achievement of biochemical control and prevention of target organ complications. Parathyroidectomy is the current recommended intervention to cure the disease. However, Cinacalcet is an alternative medical treatment for subgroup of patients in whom surgery is deemed inappropriate, those with recurrent disease, and as bridging therapy for delayed operation particularly in recent COVID pandemic. Current ...